Anna Bill‐Axelson
- Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Diagnosis and Treatment 63
- Prostate Cancer Treatment and Research 58
- Oncology top 2%
- Global Cancer Incidence and Screening 12
- Cancer survivorship and care 9
- Urology top 1%
- Rheumatology top 1%
- Statistics and Probability top 1%
-
- Bladder and Urothelial Cancer Treatments 15
- Genital Health and Disease 4
-
- Health Systems, Economic Evaluations, Quality of Life 9
-
- Cancer, Lipids, and Metabolism 4
Anna Bill‐Axelson
74 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 4.5k
- Oncology 1.5k
- Urology 319
- Rheumatology 670
- Statistics and Probability 316
Countries citing papers authored by Anna Bill‐Axelson
This map shows the geographic impact of Anna Bill‐Axelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bill‐Axelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bill‐Axelson more than expected).
Fields of papers citing papers by Anna Bill‐Axelson
This network shows the impact of papers produced by Anna Bill‐Axelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bill‐Axelson. The network helps show where Anna Bill‐Axelson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Bill‐Axelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 4 | |
| 6 | 2019 | 8 | |
| 7 | Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-upbreakdown → | 2018 | 284 |
| 8 | 2018 | 9 | |
| 9 | 2018 | 81 | |
| 10 | 2017 | 11 | |
| 11 | 2014 | 25 | |
| 12 | 2014 | 15 | |
| 13 | Radical Prostatectomy or Watchful Waiting in Early Prostate Cancerbreakdown → | 2014 | 643 |
| 14 | 2012 | 38 | |
| 15 | Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancerbreakdown → | 2011 | 778 |
| 16 | 2011 | 57 | |
| 17 | 2010 | 63 | |
| 18 | 2009 | 88 | |
| 19 | 2008 | 75 | |
| 20 | 2006 | 26 |
About Anna Bill‐Axelson
Anna Bill‐Axelson is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Urology, Internal Medicine and Statistics and Probability, having authored 79 papers that have together received 5.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (63 papers), Prostate Cancer Treatment and Research (58 papers), Bladder and Urothelial Cancer Treatments (15 papers), Global Cancer Incidence and Screening (12 papers), Cancer survivorship and care (9 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Cancer, Lipids, and Metabolism (4 papers) and Genital Health and Disease (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.5k citations), Oncology (1.5k citations), Urology (319 citations), Rheumatology (670 citations) and Statistics and Probability (316 citations). Anna Bill‐Axelson has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Lars Holmberg, Hans Garmo, Jan‐Erik Johansson, Hans‐Olov Adami, Michael Häggman, Juni Palmgren, Gunnar Steineck, Christer Busch, Anders Spångberg and Swen‐Olof Andersson. Their work appears in journals such as European Urology, European Journal of Cancer, The Journal of Urology, New England Journal of Medicine and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.